State Key Laboratory for Emerging Infectious Diseases

HKU’s COVID-19 vaccine candidate approved for human clinical trial

The vaccine candidate against Covid-19 co-developed by HKU’s State Key Laboratory for Emerging Infectious Diseases (the SKL), has been approved…